Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the…
The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a planned national clinic network, and…
Nightfood Holdings new executives have strong track records in a variety of spaces NGTF's new leadership team is poised to…
Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has received regulatory clearance under Italy’s Golden Power regulation to proceed with its option…
CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present at the Brain Tumor Biotech…
Buprenorphine is a medication approved by the U.S. Food and Drug Administration (“FDA”) to treat opioid use disorder and chronic…
Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) has released results from its 2024 exploration program at the Epworth Project in Nunavut,…
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has taken its first step toward…
ESGold (CSE: ESAU) (OTCQB: ESAUF) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial spotlighting the emerging class of near-term gold…
Fiscal 2025 marked record revenues of nearly $299 million, with silver production of 6.9 million ounces and 11% year-over-year growth…